Cargando…

Lesionalized Therapy beyond Personalized Therapy in Cancer Management

Detalles Bibliográficos
Autores principales:	Chung, June-Key, Kim, Mi Jeong, Youn, Hyewon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2014
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214931/ https://www.ncbi.nlm.nih.gov/pubmed/25368484 http://dx.doi.org/10.3346/jkms.2014.29.10.1331

Ejemplares similares

Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapy
por: Youn, Hyewon, et al.
Publicado: (2015)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
por: Chung, June-Key, et al.
Publicado: (2014)

Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression
por: Na, Juri, et al.
Publicado: (2023)

Glucose–Thymidine Ratio as a Metabolism Index Using (18)F-FDG and (18)F-FLT PET Uptake as a Potential Imaging Biomarker for Evaluating Immune Checkpoint Inhibitor Therapy
por: Oh, Sera, et al.
Publicado: (2022)

Precision Medicine for Personalized Cancer Therapy
por: Wong, Ada Hang-Heng, et al.
Publicado: (2015)

Emerging Cellular Therapies: T Cells and Beyond
por: Todryk, Stephen, et al.
Publicado: (2019)

Beyond the survey, to the ideal therapy for Asian
por: Jo, Ki Jae, et al.
Publicado: (2023)

Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake
por: Chung, Taemoon, et al.
Publicado: (2015)

Innovations in Personalized and Targeted Therapies for Breast Cancer
por: Harris, Eleanor E. R., et al.
Publicado: (2018)

Personalized Medicine: Recent Progress in Cancer Therapy
por: Hoeben, Ann, et al.
Publicado: (2021)

Personalized Therapy of Sarcomas
por: Desar, Ingrid M. E., et al.
Publicado: (2023)

Low-grade lymphoma: Beyond fludarabine-single therapy
por: Park, Eunkyung
Publicado: (2011)

Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells
por: Jung, Kyung Oh, et al.
Publicado: (2016)

Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back
por: Uemura, Hirotsugu, et al.
Publicado: (2012)

Aptamedicine: a new treatment modality in personalized cancer therapy
por: Vandghanooni, Somayeh, et al.
Publicado: (2019)

Leading New Frontiers in Vulva Cancer to Build Personalized Therapy
por: Corrado, Giacomo, et al.
Publicado: (2022)

Beyond the Valve: Lifelong Management of Right Ventricular Outflow Tract Lesion in Adult Congenital Heart Disease
por: Lee, Chang-Ha
Publicado: (2022)

From CARs to TRUCKs and Beyond: Safely en Route to Adoptive T-cell Therapy for Cancer
por: Dummy
Publicado: (2016)

Personalized Diagnosis and Therapy for Multiple Sclerosis
por: Ramo-Tello, Cristina
Publicado: (2022)

The Future of Virtual Reality Therapy for Phobias: Beyond Simple Exposures
por: Miloff, Alexander, et al.
Publicado: (2020)

The Role of Radiation in Cancer Treatment: New Insights towards Personalized Therapies
por: Minafra, Luigi, et al.
Publicado: (2022)

Surgery for Non-Small Cell Lung Cancer in the Personalized Therapy Era
por: Chiappetta, Marco, et al.
Publicado: (2023)

Going beyond efficacy: supportive care and addressing the toxicity of systemic therapy
por: Verma, S.
Publicado: (2008)

Pharmacogenomics: a key component of personalized therapy
por: Schwab, Matthias, et al.
Publicado: (2012)

Personalized Therapy and Clinical Outcome for Heart Failure
por: Aceña, Alvaro, et al.
Publicado: (2022)

Special Issue “Personal Therapy for Blood Disorders”
por: Hernandez-Valladares, Maria
Publicado: (2023)

Psoriasis and Cardiovascular Disease: Lesion Beyond the Skin
por: Bacchiega, Bruno Cesar
Publicado: (2019)

Diet Therapy and Public Health
por: Mchiza, Zandile June-Rose
Publicado: (2022)

Accessing targeted therapies for cancer: self and collective advocacy alongside and beyond mainstream cancer charities
por: Kerr, Anne, et al.
Publicado: (2021)

The management of urothelial cancer in 2010 and beyond
por: Soloway, Mark S.
Publicado: (2011)

Heart Failure and Breast Cancer Therapies: Moving Towards Personalized Risk Assessment
por: Francis, Sanjeev A., et al.
Publicado: (2014)

Thyroid-Related Protein Expression in the Human Thymus
por: Kim, Mi Jeong, et al.
Publicado: (2017)

Diabetes Management beyond Pregnancy
por: Song, Geng, et al.
Publicado: (2017)

Nutlin-3a for age-related macular degeneration
por: Chung, Hyewon, et al.
Publicado: (2022)

Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas
por: Chung, Taemoon, et al.
Publicado: (2016)

Navigating Generative AI: Opportunities, Limitations, and Ethical Considerations in Massage Therapy and Beyond
por: Baskwill, Amanda
Publicado: (2023)

Efficacy and Safety of Human Serum Albumin–Cisplatin Complex in U87MG Xenograft Mouse Models
por: Park, Cho Rong, et al.
Publicado: (2020)

Codon-optimized Human Sodium Iodide Symporter (opt-hNIS) as a Sensitive Reporter and Efficient Therapeutic Gene
por: Kim, Young-Hwa, et al.
Publicado: (2015)

Endovascular Therapy for Complex Iliac Lesions: There Is Much More to Be Defined
por: Alansari, Yahya, et al.
Publicado: (2022)

Toward Personalized Cell Therapies by Using Stem Cells
por: Isobe, Ken-ichi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4pcnr8nvnnrqvke07uuqsm0p7s